ACRP blog
MAY 5, 2025
This is a sponsored message. If you’ve led a clinical development program, you likely know something all too well: theres a constrained pipeline of qualified principal investigators (PIs), and a high prevalence of “one-and-done” PIs. About half of all PIs conduct only a single clinical trial in their careers before walking away. This isn’t simply another negative byproduct of turnover.
Bio Pharma Dive
MAY 5, 2025
The cuts to three advanced drug programs were “inevitable” given the company’s “unsustainable cash burn,” one analyst wrote in a note to investors.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
MAY 5, 2025
The US FDA has accepted Novo Nordisks new drug application (NDA) submission for the 25 mg oral formulation of Wegovy (semaglutide).
Bio Pharma Dive
MAY 5, 2025
The firm, a prolific backer of drug startups, will use the cash to back companies working on therapeutics, medical devices and healthcare services.
Speaker: Brian Richardson, Brian Richardson, Founder and CEO of Richardson Consulting Group
Let’s face it—most ethics and compliance trainings aren’t winning awards for engagement. But that doesn’t mean they can’t be effective, relevant, and maybe even enjoyable! Join expert Brian Richardson for a dynamic session on how to breathe new life into your ethics and compliance training programs. You’ll discover creative strategies to turn traditionally dry topics into meaningful learning experiences that resonate and drive real change.
Pharmaceutical Technology
MAY 5, 2025
TAE Life Sciences (TLS) has signed a letter of intent with the OSUCCC James to develop boron-based drug compounds for cancer therapy.
Bio Pharma Dive
MAY 5, 2025
While updated study results confirmed the drug lowers a target protein, the therapy's effect on clinical outcomes was less clear-cut.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Drug Patent Watch
MAY 5, 2025
"The Telehealth Revolution: How D2C Pharmacies Are Redefining the Industry In a seismic shift, direct-to-consumer (D2C) pharmacies like Ro, Hims, and Hers are upending traditional healthcare business models, leveraging telehealth to deliver convenient, affordable, and personalized care to millions. But what's driving this transformation, and what does it mean for the future of pharmaceuticals?
pharmaphorum
MAY 5, 2025
FDA decision on oral Wegovy coming in Q4 Jonah.
Drug Patent Watch
MAY 5, 2025
"As the world grapples with the complexities of global healthcare, one nation is rewriting the rules of the pharmaceutical game: South Africa. In a groundbreaking new report, we delve into the pivotal role the country is playing in shaping the future of medicine. From pioneering generic drug production to challenging Big Pharma's dominance, South Africa is redefining what it means to be a leader in the global pharmaceutical landscape.
Pharmaceutical Commerce
MAY 5, 2025
Tiara Green, president, Accessia Health, explains how empowering trusted local leaders and involving communities early are key to closing persistent gaps in preventive care and healthcare access.
Advertisement
Enhancing Transparency & Efficiency Throughout the Trial Lifecycle for AI Readiness
Drug Channels
MAY 5, 2025
Participate in Claritas Rx's upcoming webinar to learn innovative strategies designed to increase your fill rates by 20% and enhance patient adherence. The webinar seeks to elevate your operational efficiency and improve patient care standards. Join Claritas Rx experts as they lead you through methods intended to optimize patient care coordination, featuring an in-depth real-world case study that demonstrates the impact of these approaches.
Pharmaceutical Commerce
MAY 5, 2025
Chip Parkinson, CEO, GiftHealth, explains how AI-powered data integration is bringing new hope to patients by revealing hidden access barriers, streamlining treatment pathways, and challenging outdated utilization management practices.
ProRelix Research
MAY 5, 2025
This report provides a comprehensive breakdown of clinical trial costs by phase and therapeutic area, with a focus on key cost components including per-patient costs, total costs, CRO fees, and […] The post Phase-by-Phase Clinical Trial Costs: What Every Sponsor Needs to Know! appeared first on ProRelix Research.
Pharmaceutical Commerce
MAY 5, 2025
Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.
Speaker: Amie Phillips Pablo, VP, Corporate Compliance & Privacy Officer at Novo Nordisk
XTalks
MAY 5, 2025
As the weather warms up and the sun shines longer, May marks Skin Cancer Awareness Month 2025. It’s a reminder of the importance of protecting our skin, the bodys largest organ, from one of the most common yet highly preventable cancers. With over 5 million cases diagnosed each year in the US alone, skin cancer is the most common cancer in the country.
Pharmaceutical Commerce
MAY 5, 2025
How the 2028 Medicare drug price negotiations will reshape market access, provider reimbursement, and patient care
pharmaphorum
MAY 5, 2025
The UK is said to be preparing a 50m scheme to attract top scientific talent from other countries, including US teams facing big funding cuts.
pharmaphorum
MAY 5, 2025
Trump's 2026 budget request envisages sweeping cuts to funding for the NIH and other federal agencies that will be a disaster, say science advocates
Advertisement
Download this comprehensive guide to AI and ML in the R&D Laboratory Setting.
Expert insights. Personalized for you.
59 
Let's personalize your content